+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Metastatic Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
Hematopoietic Progenitor Kinase 1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Hematopoietic Progenitor Kinase 1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Ovarian Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Ovarian Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Aurora Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Aurora Kinase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Brain Metastasis From Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Metastasis From Breast Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Histone Deacetylase 6 - Pipeline Insight, 2025 - Product Thumbnail Image

Histone Deacetylase 6 - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors- Pipeline Insight, 2025 - Product Thumbnail Image

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Spleen Tyrosine Kinase (SYK) Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Spleen Tyrosine Kinase (SYK) Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
Proteasome Inhibitors Market 2025-2029 - Product Thumbnail Image

Proteasome Inhibitors Market 2025-2029

  • Report
  • May 2025
  • 243 Pages
  • Global
From
Bispecific Antibodies for Cancer Market 2025-2029 - Product Thumbnail Image

Bispecific Antibodies for Cancer Market 2025-2029

  • Report
  • February 2025
  • 233 Pages
  • Global
From
CAR T-cell Therapy Market 2025-2029 - Product Thumbnail Image

CAR T-cell Therapy Market 2025-2029

  • Report
  • January 2025
  • 199 Pages
  • Global
From
Antibody Drug Conjugates Market 2025-2029 - Product Thumbnail Image

Antibody Drug Conjugates Market 2025-2029

  • Report
  • January 2025
  • 189 Pages
  • Global
From
Small Molecule API Market 2024-2028 - Product Thumbnail Image

Small Molecule API Market 2024-2028

  • Report
  • November 2024
  • 159 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more